Protocol Details
Studies of the Natural History of Sickle Cell Disease
This study is currently recruiting participants.
Summary
Number | 04-H-0161 |
Sponsoring Institute | National Heart, Lung and Blood Institute (NHLBI) |
Recruitment Detail | Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 2 Years
Max Age: 90 Years |
Referral Letter Required | No |
Population Exclusion(s) | None |
Keywords | Hemoglobin;
Acute Chest Syndrome;
Treatment Options;
Nitric Oxide;
Pulmonary Hypertension;
Natural History |
Recruitment Keyword(s) | None |
Condition(s) | Pain Crisis |
Investigational Drug(s) | None |
Investigational Device(s) | None |
Intervention(s) | None |
Supporting Site | National Heart, Lung, and Blood Institute |
This study is not a treatment protocol and no experimental treatments are involved. Study participants may be seen as needed for clinical, translational and basic research studies, or as medically indicated. Subjects will receive their general medical care outside the NIH and will be seen at our clinic or at CNHS with varying frequency. Subjects may be seen for multiple visits. Subjects may be asked to return for additional testing as needed. Clinical care for patients with sickle cell disease will be provided as appropriate through the Sickle Cell Clinic and the inpatient clinical center.
Eligibility
INCLUSION CRITERIA:
-Individuals with known or suspected sickle cell disease
-2 years of age and older
-Willing to provide informed consent or appropriate informed consent from parent or legal guardian
-Patients seen at sickle outpatient clinics at any one of the participating centers (CNHS or NIH).
EXCLUSION CRITERIA:
-Patient and/or guardian unable and unwilling to give informed consent or assent.
-Patients less than 2 years of age.
Individuals with known or suspected sickle cell disease will meet the inclusion criteria to enroll in this protocol and can undergo study activities. However, if the individual is found not to have sickle cell disease after enrollment, they will be removed from the protocol, and their research samples will be discarded but they will be counted toward the study accrual. The study team will notify the individual about their removal from the study and explain the reason for it. Any necessary regulatory reporting will also be completed.
Citations:
Not Provided
Contacts:
Clinical Trials Number:
NCT00081523